Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Emphysema

NCT ID: NCT01305668

Last Updated: 2014-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-08-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease has two heterogeneous conditions (chronic bronchitis and pulmonary emphysema phenotypes) with a different clinical presentation.

The phenotype evaluation in COPD patient (trough clinical, functional and radiographic parameters) could influence final results in pharmacologic and non-pharmacologic management of the disease.

The aim of our study is to investigate whether COPD patients with different disease phenotype (chronic bronchitis versus pulmonary emphysema) have a different response to PR.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease Emphysema

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

COPD Emphysema phenotype

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emphysema phenotype

No interventions assigned to this group

No-Emphysema phenotype

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD disease with any functional grade
* Adherence to participate to a pulmonary rehabilitation program

Exclusion Criteria

* Recent acute exacerbation (4 weeks preceding enrollment)
* Acute severe concomitant cardiovascular diseases
* Concomitant neoplastic diseases
* NO-Adherence to participate to a pulmonary rehabilitation program
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Villa Pineta Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Clini Enrico

Villa Pineta Hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Enrico M Clini, MD

Role: STUDY_DIRECTOR

Villa Pineta Hospital and University of Modena and Reggio Emilia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione Maugeri IRCCS

Lumezzane, Brescia, Italy

Site Status

Villa Pineta Hospital

Pavullo nel Frignano, Modena, Italy

Site Status

Auxilium Vitae Rehabilitation Center

Volterra, Pisa, Italy

Site Status

Ospedale San Raffaele

Velletri, Roma, Italy

Site Status

Clinic Center

Naples, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VP-01-2011

Identifier Type: -

Identifier Source: org_study_id